Carnitine palmitoyl transferase 1A deficiency


Disease Overview

Carnitine palmitoyltransferase I deficiency (CPT1A deficiency) is an inherited metabolic condition that prevents the body from converting certain fats  (long-chain fatty acids) into energy, particularly during periods without food. Carnitine, a natural substance acquired mostly through the diet, is required by cells to process fats and produce energy. Symptoms of this condition often appear early in life and include low blood sugar (hypoglycemia) and low levels of ketones, which are produced when the body breaks down fat for energy (hypoketotic hypoglycemia). This can lead to a greater risk for loss of consciousness or seizures. People with this disorder typically also have an enlarged liver (hepatomegaly), muscle weakness, nervous system damage, and elevated levels of carnitine in the blood. CPT1A deficiency is caused by mutations in the CPT1A gene and is inherited in an autosomal recessive manner. Although there is no cure for CPT1A deficiency, symptoms can be managed using several strategies, such dietary changes and use of fat supplements.[1373][12578]


  • Carnitine palmitoyltransferase 1A deficiency
  • CPT1A deficiency
  • Hepatic CPT1
  • Hepatic carnitine palmitoyltransferase 1 deficiency
  • L-CPT 1 deficiency
  • Carnitine palmitoyl transferase IA deficiency
  • Hepatic carnitine palmitoyl transferase 1 deficiency
  • Hepatic carnitine palmitoyl transferase I deficiency
  • L-CPT1 deficiency
  • L-CPTI deficiency

For more information, visit GARD.

National Organization for Rare Disorders